Last reviewed · How we verify
A Phase I Clinical Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion
The purpose of this study is to evaluate the safety and tolerability of nemonoxacin in healthy Chinese volunteers.
Details
| Lead sponsor | TaiGen Biotechnology Co., Ltd. |
|---|---|
| Phase | Phase 1 |
| Status | COMPLETED |
| Enrolment | 176 |
| Start date | 2008-09 |
| Completion | 2011-03 |
Conditions
- Healthy
Interventions
- Nemonoxacin Malate Sodium Chloride
Primary outcomes
- Adverse event assessment in healthy Chinese volunteer — 46days
- Maximum tolerated single dose of nemonoxacin in healthy Chinese volunteers — 32days
Countries
China